[Malignant melanoma of the skin. Epidemiology, risk factors, clinical diagnosis]
- PMID: 8925536
[Malignant melanoma of the skin. Epidemiology, risk factors, clinical diagnosis]
Abstract
The incidence of malignant melanoma of the skin in the white population worldwide is rising and the mortality from this tumour is also rising. It is assumed that this trend will proceed also in coming years. While in 1970 in the Czech Republic 3.2 new cases of malignant melanoma per 100,000 population were reported, in 1990 the rate was already 8.1 and at present the number of notified cases is close to 10/100,000 population. An important risk factor for the development of malignant melanoma is solar radiation, in particular its UV component. Specially intermittent exposure of the skin to intense, even brief exposure to solar radiation with subsequent sunburn is very dangerous, in particular during childhood. People with type I and II skin are particularly threatened. The increased risk of development of malignant melanoma correlates also with the increased number of acquired melanocytic naevi. Investigation and evaluation of risk factor analyses facilitates screening of people at risk and their early treatment. In the clinical diagnosis four types of malignant melanoma of the skin are differentiated: lentigo maligna melanoma (LMM), superficially spreading melanoma (SSM), nodular melanoma (NM) and acrolentiginous melanoma (ALM). The author mentions the characteristics of different forms and signs which facilitate their early detection.
Similar articles
-
[Malignant melanoma of the skin in Denmark--epidemiology, diagnosis and treatment].Ugeskr Laeger. 1992 Jul 6;154(28):1949-53. Ugeskr Laeger. 1992. PMID: 1509557 Review. Danish.
-
Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).Cancer Causes Control. 2005 Oct;16(8):893-9. doi: 10.1007/s10552-005-2300-4. Cancer Causes Control. 2005. PMID: 16132799 Clinical Trial.
-
Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.J Eur Acad Dermatol Venereol. 2005 May;19(3):332-9. doi: 10.1111/j.1468-3083.2005.01196.x. J Eur Acad Dermatol Venereol. 2005. PMID: 15857460
-
Skin surveillance of a U.K. paediatric transplant population.Br J Dermatol. 2007 Jan;156(1):45-50. doi: 10.1111/j.1365-2133.2006.07546.x. Br J Dermatol. 2007. PMID: 17199565
-
Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors.Semin Surg Oncol. 1993 May-Jun;9(3):165-7. Semin Surg Oncol. 1993. PMID: 8516598 Review.
Cited by
-
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.J Immunol Res. 2020 Jun 28;2020:9235638. doi: 10.1155/2020/9235638. eCollection 2020. J Immunol Res. 2020. PMID: 32671117 Free PMC article. Review.
-
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.Nucl Med Biol. 2007 Nov;34(8):945-53. doi: 10.1016/j.nucmedbio.2007.07.003. Epub 2007 Sep 4. Nucl Med Biol. 2007. PMID: 17998097 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical